Accelerating Breakthrough Discoveries into Medicines

Ferozrpapa from OptiKira talking in a lab

Scientists in lab examining solution

From research institutions to patients

BioMotiv is the mission-driven development company associated with The Harrington Project for Discovery & Development, a national initiative centered at University Hospitals Cleveland Medical Center. The company’s focus is accelerating breakthrough discoveries from research institutions into therapeutics for patients.

Led by experienced industry professionals

BioMotiv has a capable and connected management team, advisory board, and Board that oversee the development, funding, active management, and partnering of the portfolio of therapeutic products.

Pharmaceutical Expertise

Our leadership and portfolio teams are well-versed in translational science, with deep pharmaceutical experience having supported the advancement of numerous programs into clinical development and into the marketplace.

Deep Business Networks

Through their careers, the company’s leadership team and advisory board members have developed broad relationships in the investment and pharmaceutical industries that are available to be accessed by BioMotiv companies.

Partnered with leading companies

Working with
The Harrington Project
to bridge the Valley of Death


2018 Harrington Scholar-Innovators Selected

CLEVELAND, OHIO, January 18 – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, part of The Harrington Project for Discovery & Development, has announced its 2018 Harrington Scholar-Innovator Award recipients.  The 10...

Social Finance Forum: Navigating Impact in Health

TORONTO, November 2017 – Baiju Shah joined international leaders in the social finance and impact investing space for the 10th Annual Social Finance Forum. He represented BioMotiv on the Navigating Impact in Health panel to discuss innovative approaches to the drug...

Collaboration in Action: Drug Discovery Alliance Models

BOSTON, November 2017 —  The Association of Strategic Alliance Professionals hosted the 2017 BioPharma Conference. BioMotiv’s Senior Vice President, Technical Operations, Chuck McOsker, PhD, represented BioMotiv on the panel discussing Strategic Perspectives on...